Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats

Journal of Surgical Research

Volumn 85, Issue 2, 1999, Pages 294-300

  Kruse, Peter ^a   Lasson, Åke ^b   Hage, Esther ^c  

^a Mental Health Services CPH   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Rigshospitalet   (Denmark)

Author keywords

Acute pancreatitis; Animal models; Cerulein; Enzyme precursors; Protease inhibitors

Indexed keywords

ALPHA 1 ANTITRYPSIN; CERULETIDE; KALLIKREIN; KININ; PROTEINASE; PROTEINASE INHIBITOR;

ACUTE PANCREATITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HISTOLOGY; INFLAMMATION; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT;

EID: 0032815280     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5609     Document Type: Article

References (48)

1. Gorelick F. S., Adler G., Kern H. F. Cerulein-induced pancreatitis. Go W. The Pancreas: Biology, Pathobiology and Diseases. 1993;501-526 Raven, New York.
2. Bieger W., Martin-Achard A., Bassler M., Kern H. F. Studies on intracellular transport of secretory proteins in the rat exocrine pancreas. IV. Stimulation by in vivo infusion of caerulein. Cell Tissue Res. 165:1976;435.
3. Willemer S., Elsasser H. P., Adler G. Hormone-induced pancreatitis. Eur. Surg. Res. 24:1992;29.
4. Takano S., Kimura T., Kawabuchi M., Yamaguchi H., Kinjo M., Nawata H. Ultrastructural study of the effects of stress on the pancreas in rats. Pancreas. 9:1994;249.
5. Kingsnorth A. Mediators in acute pancreatitis. Scand. J. Gastroenterol. Suppl. 31:1996;1.
6. Rao K. N., Tuma J., Lombardi B. Acute hemorrhagic necrosis in mice. Gastroenterology. 70:1976;720.
7. Ohlsson K., Olsson R., Bjork P., Balldin G., Borgstrom A., Lasson A. Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs. Scand. J. Gastroenterol. 24:1989;693.
8. Lium B., Ruud T. E., Pillgram-Larsen J., Stadaas J. O., Aasen A. O. Sodium taurocholate-induced acute pancreatitis in pigs. Pathomorphological studies of the pancreas in untreated animals and animals pretreated with high doses of corticosteroids or protease inhibitors. Acta Pathol. Microbiol. Immunol. Scand. A. 95:1987;377.
9. Lasson A., Ohlsson K. Acute pancreatitis. The correlation between clinical course, protease inhibitors, and complement and kinin activation. Scand. J. Gastroenterol. 19:1984;707.
10. Büchler M., Friess H., Uhl W., Beger H. G. Clinical relevance of experimental acute pancreatitis. Eur. Surg. Res. 24:1992;85.
11. Schoenberg M. H., Büchler M., Beger H. G. Experimental models in acute pancreatitis. Jeppsson B. Animal Modelling in Surgical Research. 1998;135-142 Harwood Academic, Amsterdam.
12. Friess H., Weber A., Buchler M. Standards in monitoring acute experimental pancreatitis. Eur. Surg. Res. 24:1992;1.
13. Laurell C. B. Electroimmunoassay. Scand. J. Clin. Lab. Invest. 29:1972;21.
14. Gallimore M. J., Friberger P. Chromogenic peptide substrate assay and their clinical applications. Blood Rev. 5:1991;117.
15. Matsuzawa T., Nomura M., Unno T. Clinical pathology reference ranges of laboratory animals. J. Vet. Med. Sci. 55:1993;351.
16. Gauthier F., Genell S., Mouray H., Ohlsson K. The in vitro interactions of rat pancreatic elastase and normal inflammatory rat serum. Biochim. Biophys. Acta. 526:1978;218.
17. Koj A., Magielska-Zero D., Kurdowska A., Bereta J. Proteinase inhibitors as acute phase reactants: Regulation of synthesis and turnover. Adv. Exp. Med. Biol. 240:1988;171.
18. Kumada T., Abiko Y. Physiological role of alpha 2-plasmin inhibitor in rats. Thromb. Res. 36:1984;153.
19. Karges H. E., Funk K. A., Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneim. Forsch. Drug Res. 44:1994;793.
20. Deng X., Sun Z., Lasson Å., Wang X., Andersson R. Alterations in the functions of the reticuloendothelial and protease-antiprotease systems after intraperitoneal injections of Zymosan in rats. Eur. J. Surg. 164:1998;605.
21. Tani S., Otsuki M., Itoh H., Fujii M., Nakamura T., Oka T. Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulein stimulation. Int. J. Pancreatol. 2:1987;337.
22. Siegel S., Castellan N. J. Nonparametric Statistics for the Behavioral Sciences. 1988;McGraw-Hill, New York.
23. Adler G., Rohr G., Kern H. F. Alteration of membrane fusion as a cause of acute pancreatitis in the rat. Dig. Dis. Sci. 27:1982;993.
24. Adler G., Kern H. F. Fine structural and biochemical studies in human acute pancreatitis. Gyr K. E., Singer M. V., Sarles H. Pancreatitis - Concepts and classification. 1984;37-42 Elsevier Science, Amsterdam.
25. Silverman M., Ilardi C., Bank S., Kranz V., Lendvai S. Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice (see comments). Gastroenterology. 96:1989;186.
26. Schoenberg M. H., Buchler M., Gaspar M., Stinner A., Younes M., Melzner I. Oxygen free radicals in acute pancreatitis of the rat. Gut. 31:1990;1138.
27. Willemer S., Adler G. Histochemical and ultrastructural characteristics of tubular complexes in human acute pancreatitis. Dig. Dis. Sci. 34:1989;46.
28. Elsasser H. P., Adler G., Kern H. F. Fibroblast structure and function during regeneration from hormone-induced acute pancreatitis in the rat. Pancreas. 4:1989;169.
29. Cochrane C. G., Griffin J. H. The biochemistry and pathophysiology of the contact system of plasma. Adv. Immunol. 33:1982;241.
30. Wachtfogel Y. T., DeLa Cadena R. A., Colman R. W. Structual biology, cellular interactions and pathophysiology of the contact system. Thromb. Res. 72:1993;1.
31. Shimizu I., Wada S., Okahisa T., Kamamura M., Yano M., Kodaira T. Radioimmunoreactive plasma bradykinin levels and histological changes during the course of cerulein-induced pancreatitis in rats. Pancreas. 8:1993;220.
32. Seelig R., Seelig H. P. The possible role of serum complement system in the formal pathogenesis of acute pancreatisis. I. Immunopathogenetic pancreatitis - local Schwartzman-Sanarelli phenomenon - endotoxin induced pancreatitis. Acta Hepatogastroenterol. (Stuttg.). 22:1975;263.
33. Weiser M. R., Gibbs S. A., Moore F. D. Jr., Hechtman H. B. Complement inhibition by soluble complement receptor type 1 fails to moderate cerulein-induced pancreatitis in the rat. Int. J. Pancreatol. 19:1996;129.
34. Kruse P., Hage E., Lasson Å. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats. Int. J. Pancreatol. 1999.
35. Sun Z. W., Wang X., Deng X., Lasson Å., Wallén R., Hallberg E. The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, protease inhibitors and cell death in rats. Shock. 1999.
36. Högstorp H. J., Jacobsson H., Carlin G. Effect of hepatectomy on the post-traumatic fibrinolysis inhibition and the primary fibrinolysis inhibitor in the rat. Thromb. Res. 18:1980;361.
37. Bergsma J., Boelen K. M., Duursma A. M., Schutter W. G., Bouma J. M. W., Gruber M. Complexes of rat alpha-1-macroglobulin and subtilisin are endocytosed by parenchymal liver cells. Biochem. J. 226:1985;75.
38. Foitzik T., Lewandrowski K. B., Fernandez-del Castillo C., Rattner D. W., Warshaw A. L. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis. Surgery. 115:1994;698.
39. Lungarella G., Gardi C., de Santi M. M., Luzi P. Pulmonary vascular injury in pancreatitis: evidence for a major role played by pancreatic elastase. Exp. Mol. Pathol. 42:1985;44.
40. Gauthier F., Genell S., Mouray H., Ohlsson K. Interactions in vitro and in vivo between rat serum protease inhibitors and anodal and cathodal rat trypsin and chymotrypsin. Biochim. Biophys. Acta. 566:1979;200.
41. Brower H. S., Harpel P. C. Proteolytic cleavage and inactivation of a-2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. J. Biol. Chem. 257:1982;9849.
42. Tsuji A., Akamatsu T., Nagamune H., Matsuda Y. Identification of targeting proteinase for rat alpha-1-macroglobulin. Biochem. J. 298:1994;79.
43. Schmidt J., Rattner D. W., Lewandrowski K., Compton C. C., Mandavilli U., Knoefel W. T. A better model of acute pancreatitis for evaluating therapy. Ann. Surg. 215:1992;44.
44. Largman C., Reidelberger R. D., Tsukamoto H. Correlation of trypsin-plasma inhibitor complexes with mortality in experimental pancreatitis in rats. Dig. Dis. Sci. 31:1986;961.
45. Merriam L. T., Wilcockson D., Samuel I., Joehl R. J. Ligation-induced acute pancreatitis increases pancreatic and circulating trypsinogen activation peptides. J. Surg. Res. 60:1996;417.
46. Rydzewska G., Kosidlo S., Gabryelewicz A., Rydzewski A. Tissue plasminogen activator, plasminogen activator inhibitor, and other parameters of fibrinolysis in the early stages of taurocholate acute pancreatitis in rats. Int. J. Pancreatol. 11:1992;161.
47. Gabryelewicz A., Kosidlo S., Prokopowicz J., Podkowicz K. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats. Hepatogastroenterology. 33:1986;79.
48. Schmidt J., Fernandez-del Castillo C., Rattner D. W., Lewandrowski K., Compton C. C., Warshaw A. L. Trypsinogen-activation peptides in experimental rat pancreatitis: Prognostic implications and histopathologic correlates. Gastroenterology. 103:1992;1009.